SCHEMBL6029434

SCHEMBL6029434

Cc1ccc(C(=S)NC2CCC(N)CC2NC(=O)CNC(=O)c2cccc(C(F)(F)F)c2)cc1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3892968 1.00 CCR2 (0.71) CCR2
SCHEMBL3890044 0.89 CCR2 (0.84) CCR2
SCHEMBL3890055 0.89 CCR2 (0.84) CCR2
SCHEMBL3890049 0.89 CCR2 (0.84) CCR2
SCHEMBL3884780 0.87 CCR2 (0.73) CCR2
SCHEMBL7104856 0.86 CCR2 (0.73) CCR2
SCHEMBL7109441 0.86 CCR2 (0.73) CCR2
SCHEMBL3888763 0.84 CCR2 (0.67) CCR2
SCHEMBL3887978 0.84 CCR2 (0.69) CCR2
SCHEMBL3888759 0.84 CCR2 (0.67) CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7045521-B2 Cyclic derivatives as modulators of chemokine receptor activity BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2006-05-16 US claimed